ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382035 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382035; 2) Community: the network communities that were significantly associated with the response to NSC 382035; 3) Molecule: the relationships between components within communities and NSC 382035; 4) MDR: the compounds that were significantly associated with the NSC 382035.

NSC Compound Enrichment Correlation
NSC 371777 Null 0.000455867606843412 0.36484878
NSC 694620 Null 0.000455867606843419 -0.27066731
NSC 725666 6-[(5-Morpholyl-3-aminoethyl)-1-propyl]-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline 0.000455867606843419 0.53929314
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.000463656464354233 0.70318964
NSC 670995 Null 0.000463656464354236 0.5473119
NSC 689627 Null 0.000463656464354236 0.54329126
NSC 639977 Null 0.000572036815736145 0.3466453
NSC 740 Methotrexate 0.000572036815736145 0.85908546
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.000572036815736145 0.38970003
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.000572036815736153 0.51153856
Total:112  Current:4    [First] [Prev] [Next] [Last]